63 related articles for article (PubMed ID: 10964485)
1. Long-term expression driven by herpes simplex virus type-1 amplicons may fail due to eventual degradation or extrusion of introduced transgenes.
Tsai DJ; Ho JJ; Ozawa CR; Sapolsky RM
Exp Neurol; 2000 Sep; 165(1):58-65. PubMed ID: 10964485
[TBL] [Abstract][Full Text] [Related]
2. Latency associated promoter transgene expression in the central nervous system after stereotaxic delivery of replication-defective HSV-1-based vectors.
Scarpini CG; May J; Lachmann RH; Preston CM; Dunnett SB; Torres EM; Efstathiou S
Gene Ther; 2001 Jul; 8(14):1057-71. PubMed ID: 11526453
[TBL] [Abstract][Full Text] [Related]
3. Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vectors in vivo.
Jacobs A; Tjuvajev JG; Dubrovin M; Akhurst T; Balatoni J; Beattie B; Joshi R; Finn R; Larson SM; Herrlinger U; Pechan PA; Chiocca EA; Breakefield XO; Blasberg RG
Cancer Res; 2001 Apr; 61(7):2983-95. PubMed ID: 11306477
[TBL] [Abstract][Full Text] [Related]
4. Integration of active human beta-galactosidase gene (100 kb) into genome using HSV/AAV amplicon vector.
Oehmig A; Cortés ML; Perry KF; Sena-Esteves M; Fraefel C; Breakefield XO
Gene Ther; 2007 Jul; 14(14):1078-91. PubMed ID: 17460718
[TBL] [Abstract][Full Text] [Related]
5. Long-term retinal transgene expression with FIV versus adenoviral vectors.
Loewen N; Leske DA; Cameron JD; Chen Y; Whitwam T; Simari RD; Teo WL; Fautsch MP; Poeschla EM; Holmes JM
Mol Vis; 2004 Apr; 10():272-80. PubMed ID: 15094709
[TBL] [Abstract][Full Text] [Related]
6. Herpes simplex virus-mediated gene delivery to the rodent visual system.
Spencer B; Agarwala S; Miskulin M; Smith M; Brandt CR
Invest Ophthalmol Vis Sci; 2000 May; 41(6):1392-401. PubMed ID: 10798655
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of Tet-on system to avoid transgene down-regulation in ex vivo gene transfer to the CNS.
Johansen J; Rosenblad C; Andsberg K; Møller A; Lundberg C; Björlund A; Johansen TE
Gene Ther; 2002 Oct; 9(19):1291-301. PubMed ID: 12224012
[TBL] [Abstract][Full Text] [Related]
8. Comparison of wild-type and class I integrase mutant-FIV vectors in retina demonstrates sustained expression of integrated transgenes in retinal pigment epithelium.
Loewen N; Leske DA; Chen Y; Teo WL; Saenz DT; Peretz M; Holmes JM; Poeschla EM
J Gene Med; 2003 Dec; 5(12):1009-17. PubMed ID: 14661176
[TBL] [Abstract][Full Text] [Related]
9. Gene transfer using a disabled herpes virus vector containing the EMCV IRES allows multiple gene expression in vitro and in vivo.
Wagstaff MJ; Lilley CE; Smith J; Robinson MJ; Coffin RS; Latchman DS
Gene Ther; 1998 Nov; 5(11):1566-70. PubMed ID: 9930311
[TBL] [Abstract][Full Text] [Related]
10. Studies on in vivo gene transfer in pituitary tumors using herpes-derived and adenoviral vectors.
Carri NG; Sosa YE; Brown OA; Albariño C; Romanowski V; Goya RG
Brain Res Bull; 2005 Feb; 65(1):17-22. PubMed ID: 15680541
[TBL] [Abstract][Full Text] [Related]
11. Muscle derived cell mediated ex vivo gene transfer to the lower urinary tract: comparison of viral vectors.
Pruchnic R; Yokoyama T; Lee JY; Huard J; Chancellor MB
Urol Res; 2002 Oct; 30(5):310-6. PubMed ID: 12389119
[TBL] [Abstract][Full Text] [Related]
12. Gene transfer into hepatocytes mediated by herpes simplex virus-Epstein-Barr virus hybrid amplicons.
Müller L; Saydam O; Saeki Y; Heid I; Fraefel C
J Virol Methods; 2005 Jan; 123(1):65-72. PubMed ID: 15582700
[TBL] [Abstract][Full Text] [Related]
13. Drug inducible transgene expression in brain using a herpes simplex virus vector.
Oligino T; Poliani PL; Wang Y; Tsai SY; O'Malley BW; Fink DJ; Glorioso JC
Gene Ther; 1998 Apr; 5(4):491-6. PubMed ID: 9614573
[TBL] [Abstract][Full Text] [Related]
14. Sustained transgene expression in intervertebral disc cells in vivo mediated by microbubble-enhanced ultrasound gene therapy.
Nishida K; Doita M; Takada T; Kakutani K; Miyamoto H; Shimomura T; Maeno K; Kurosaka M
Spine (Phila Pa 1976); 2006 Jun; 31(13):1415-9. PubMed ID: 16741448
[TBL] [Abstract][Full Text] [Related]
15. Towards global and long-term neurological gene therapy: unexpected transgene dependent, high-level, and widespread distribution of HSV-1 thymidine kinase throughout the CNS.
Zermansky AJ; Bolognani F; Stone D; Cowsill CM; Morrissey G; Castro MG; Löwenstein PR
Mol Ther; 2001 Nov; 4(5):490-8. PubMed ID: 11708886
[TBL] [Abstract][Full Text] [Related]
16. Highly efficient regulation of gene expression by tetracycline in a replication-defective herpes simplex viral vector.
Yao F; Theopold C; Hoeller D; Bleiziffer O; Lu Z
Mol Ther; 2006 Jun; 13(6):1133-41. PubMed ID: 16574491
[TBL] [Abstract][Full Text] [Related]
17. Acute direct adenoviral vector cytotoxicity and chronic, but not acute, inflammatory responses correlate with decreased vector-mediated transgene expression in the brain.
Thomas CE; Birkett D; Anozie I; Castro MG; Lowenstein PR
Mol Ther; 2001 Jan; 3(1):36-46. PubMed ID: 11162309
[TBL] [Abstract][Full Text] [Related]
18. Antitumor effects on human melanoma xenografts of an amplicon vector transducing the herpes thymidine kinase gene followed by ganciclovir.
Wang S; Qi J; Smith M; Link CJ
Cancer Gene Ther; 2002 Jan; 9(1):1-8. PubMed ID: 11916238
[TBL] [Abstract][Full Text] [Related]
19. Increased in vitro and in vivo transgene expression levels mediated through cis-acting elements.
Johansen J; Tornøe J; Møller A; Johansen TE
J Gene Med; 2003 Dec; 5(12):1080-9. PubMed ID: 14661183
[TBL] [Abstract][Full Text] [Related]
20. HSV-1-based amplicon vectors: design and applications.
Epstein AL
Gene Ther; 2005 Oct; 12 Suppl 1():S154-8. PubMed ID: 16231049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
